dr. tim sandle - pharmig€¦ · limitations #1 – em methods the classic techniques: active...
TRANSCRIPT
Dr. Tim Sandle
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Introduction What is environmental monitoring trying to do?
Methods and limitations
Problems and myths of incubation
Which agar should you select?
Should one or two agars be used?
Which is the optimal temperature?
For how long should you incubate for?
What types of microorganisms can you expect to detect?
Cleanroom microbiota
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Environmental monitoring To assess cleanrooms and controlled environments
using viable and particulate counting methods.
To verify environmental control (how well is the cleanroom working?)
To assess impact of staff behaviours
To help evaluate risk in relation to excursions (location and event dependent)
To assess event specific incidents e.g. HVAC losing power or maintenance works
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Limitations #1 – EM methods The classic techniques:
Active air-sampling: volumetric air-sampler
Passive air-sampling: settle plates
Surface samples: contact (RODAC) plates and swabs
Personnel samples: Finger plates and gown plates
New generation of ‘real time’ viable air samplers.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
EM method limitations #2 Settle plates
Position in relation to air currents
Desiccation Meaningfulness of one
CFU Attempt to quantify by
Whyte’s deposition rate
Active air samplers Particle size cut-off (D50
value) Recovery ~50% Different instruments
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
EM method limitations #3 Contact plates
Tidswell’s work on organism recovery (~50%)
Disinfectant residues on surfaces and neutraliser selection
Disinfectant rotation and neutralisers
Swabs
Plain swabs ~10-20% recovery
Flocked swabs 40-60% recovery
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Limitation #2 - – The CFU Often a CFU is not a
single bacterium
A colony could arise from one cell or several.
Issue can occur through: Poor sample mixing e.g.
bacteria clumping together,
Poor plate mixing,
Settle plate picking up skin detritus.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Culture media Between 70 and 90% of microorganisms in the
environment are ‘viable but non-culturable’
There is no single culture medium that will detect all of the culturable microorganisms.
Does this matter?
Should two different media be used?
There are also the variants of:
Incubation time,
Incubation temperature.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation time Avoiding ‘the chicken or the egg’ scenario:
Incubation time needs to be decided once the dual media debate and incubation temperature questions have been decided.
Maximum incubation time should be assessed for:
At what point do colony forming units stop appearing?
Is there a point when the media ceases to be able to support slow-growing microorganisms?
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation time Studying incubation time:
Sandle, T., Skinner, K. and Yeandle, E. (2013). Optimal conditions for the recovery of bioburden from pharmaceutical processes: a case study, European Journal of Parenteral and Pharmaceutical Sciences, 18 (3): 84-91
Studying the effect of desiccation of media following UDAF exposure and at the end of incubation:
Sandle, T. (2011): 'Microbial recovery on settle plates in unidirectional airflow cabinets', Clean Air and Containment Review, Issue 6, pp8-10
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
The one or two media debate Should two different culture media be used?
One to recover bacteria
One to recover fungi
Raises two questions:
A) If it is necessary, which two media?
B) Is it really necessary?
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Optimal fungal medium It is generally accepted that TSA is a good, general
medium for the recovery of bacteria.
If two media are used, what is the appropriate fungal medium?
Study:
Gebala, B. and Sandle, T. (2013). Comparison of different fungal agar for the environmental monitoring of pharmaceutical-grade cleanrooms, PDA J Pharm Sci Technol.;67(6):621-33
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Fungal media
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Fungal media study Aims:
To assess if there is any significant variation in the number of fungal isolates recovered by five selective agars.
To assess any variation in recovery of different species or genera by the selective agars.
Outcomes: Recovery of fungi was
relatively low. Mean counts varying
between 0.1 and 7.8 colonies per sample type.
Higher results from active air samplers.
Lowest results from surface contact plates.
More filamentous fungi in the environment than yeasts.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Outcome of fungal media study Agars Examined for significance
using Student’s t-test Yeats: MEA agar, followed by
SDA, recovered the greatest variety. PDA recovered the lowest variety.
Filamentous fungi: Largest variety recovered on RBA, second SDA, and the smallest variety from MEA.
PDA was less selective, recovering higher numbers of bacteria.
Optimal agar: SDA.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
One medium Regulators express an interest but no documents
produced by regulatory agencies mention types of media required.
FDA guidance for environments used for aseptic filling requires the agar to have undergone growth promotion of bacteria and fungi.
Arguments against 2 media:
Unnecessary – TSA will grow bacteria and fungi,
Increase the number of aseptic manipulations,
Costly.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
One medium Many sites use one general purpose culture medium
incubated at two temperatures:
30-35oC, to encourage the recovery of skin commensurable bacteria;
Based on the skin microbiota.
Staphylococci, Micrococci & Corynebacteria.
20-25oC, designed to recover fungi.
Based on the growth characteristics of most fungi.
Alternaria, Trichophyton, Aspergillus & Cladosporium.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
What is the appropriate order of incubation? Higher temperature:
Majority of microorganisms recovered are mesophilic bacteria.
Few fungi are recovered.
Filamentous fungi could grow and obscure bacteria.
Destruction of lytic cellular enzymes in fungi if high temperature first.
Lower temperature: Higher temperature may inhibit
fungal growth.
Higher temperature may damage fungal enzymes, leading to no recovery.
Avoids overgrowth of mycelia obscuring bacterial colonies if low temperature first.
Some bacteria may not grow at this temperature.
Sandle, T. (2014) Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical Cleanrooms, International Journal of Pharmaceutical Compounding, 18 (3): 242 – 247 Pharmaceutical Microbiology:
http://www.pharmamicroresources.com/
Incubation order study #1 Medium:
Tryptone soya agar (aka = soya-bean casein digest medium, tryptic soya agar)
Referenced in EP, USP & JP.
2 approaches:
In situ study: assessing microorganisms recovered from a cleanroom environment.
In vitro study: plating out cultured microorganisms onto TSA.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #2 Two scenarios for a two-tiered incubation scheme:
Incubate at a higher temperature first, followed by the lower temperature: Regime A: 30-35oC for 2 days, followed by 20-25oC for 5 days
Incubate at a lower temperature first, followed by the higher temperature: Regime B: 20-25oC for 5 days, followed by 30-35oC for 2 days
One of two possible outcomes: That there is a significant difference between the two
incubation regimes.
That there is not a significant difference between the two incubation regimes.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #3 Taking note of:
Time taken for the incubated plates to reach the required temperature;
Time that the plates are placed into the incubator;
The day and the time that the plates are removed from the incubator (either for temperature transfer or final read).
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #4 Study aspects:
39 cleanrooms: EU GMP Grade C / ISO 14644 class 8 (in operation) and EU GMP Grade D. Changing rooms;
Wash bays;
Corridors;
Ambient processing areas;
Cleanrooms subject to a warmer temperature (such as an autoclave preparation area);
Cold rooms (operating at 2-8°C).
Surface samples taken (contact plates). Two enable ‘close to possible’ duplicate sampling.
136 samples.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #5
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #6 The total colony count results for the incubation
regime B gave a higher mean count than those from incubation regime A A = mean count of 8 CFU/plate
B = mean count of 11 CFU/plate.
This difference was shown not to be statistically significant .
Therefore there is no optimum incubation regime for total count. If you do not find many fungi, then there is no need to
explore further.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #7 What if fungi are recovered regularly?
Out of the 136 data sets, 15 sample results showed fungal colony growth.
A greater number of fungal colonies were isolated by incubation regime B incubation regime.
Regime A recovered ~ <1 fungal colony
Regime B recovered ~11 fungal colonies.
To determine whether this was significant or nor required a second Student's t-test to be constructed.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Incubation order study #8 This time, there the difference was shown to be
statistically significant .
Therefore incubation regime B produces a higher fungal count.
Regime B: 20-25oC for 5 days, followed by 30-35oC for 2 days
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Order of incubation study #9 Does this matter?
Perhaps if there is a lot of fungi recovered?
But should fungi be being recovered in high numbers?
The most important element is consistency of practice: to use the same incubation parameters so that results can be meaningfully compared over time.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Why carry out identifications? To look for changes from the norm.
Changes from the norm may signal cleaning or disinfection concerns.
In the event of a sterility test failure.
Only genotypic comparison can invalidate.
To assist with investigations into out-of-limits results.
Grouping microorganisms into different categories.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Contamination sources
Product
Adjacent areas
Supply air
Cleanroom air
Machine and
ancillaries
Room surfaces
People
Materials
Water sources
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
The people factor Different sites on the body have different microbial
communities
Based on nutritional and physicochemical requirements:
Liebig’s law of the minimum
Microbial numbers are determined by the nutrients present
Shelford’s law of tolerance
Non-nutritional factors governing growth, such as pH and temperature
Also antimicrobial factors and mechanical removal factors, like skin shedding
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Human skin #1 Average adult has 1.8m2 of skin
Regional variation :
Temperature range 25-37oC
Warmest area under the arms (36.6oC) and the coolest area the fingers (29.5oC).
pH of the skin varies between neutral and alkali,
Forehead: pH 4.8 and under the arm: pH 6.9.
Moisture
High moisture: axilla, groin, and areas between the toes = high population density
Other areas are relatively dry
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Human skin #2 Skin #2
Cleanroom risk
With the skin epithelial cells are continually being shed so many microbial communities on the external surface are unstable.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Human skin #3 Why so many Gram-positive bacteria?
Dry environment with high osmotic pressure.
Gram-positive bacteria better adapted (resistant to desiccation).
However, certain occluded regions (such as toe webs), have more variation, including Gram-negative bacteria.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Human skin #4
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Why do microorganisms survive in cleanrooms? Varies depending upon the species and different factors:
Temperature
Available water
Concentration of organic compounds
Concentration of hydrogen ions
Concentration of inorganic compounds
Concentration of particles in the air
Redox potential
Pressure
Light intensity
Geographical location and habitat
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Types of contamination Variables affect the types of microorganisms
recovered:
Monitoring methods,
Location of the monitoring sample,
Types of agars,
Disinfectant neutralisers,
Incubation temperature,
Incubation time,
Identification method.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
What is found in cleanrooms? #1 Description of the human microbiota does not
necessarily predict the types of microorganisms found in cleanrooms.
Variations relating to: Cleanroom types and uses
Grade, temperature and humidity
Geographical location
Gowning requirements
Certain locations of the body are more likely to release organisms than others.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
What is found in cleanrooms? #2 Variations also relate to:
Microbial identification method Phenotypic or genotypic
Databases
Size, orientation (clinical or industrial)
Periodic reclassification of microorganisms
Limitations of EM methods
EM agar and incubation regime
Culturability
Some research suggest that less than 10% of bacteria found in cleanrooms are culturable
Seasonality and time of sampling
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Study Very few studies of pharmaceutical cleanroom
microflora published.
Mystudy is:
Sandle, T. (2011): ‘A Review of Cleanroom Microflora: Types, Trends, and Patterns’, PDA Journal of Pharmaceutical Science and Technology, Vol. 65, No. 4, July–August 2011, pp392-403
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Study #2 Pharmaceutical facility in south-east England
The cleanrooms examined represented:
40 Grade B rooms (of which five had Grade A cleanzones)
35 Grade C cleanrooms
20 Grade D cleanrooms
EM regime used TSA and incubation regime:
20-25oC ≤5 days / 30-35oC ≤2 days
Time period: 2001 - 2010
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Study #3 EU GMP Grade A and B clean areas = 6,729 isolates
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Study #4 Grade A and B major
species Skin related microflora
represent the most common genera isolated, with the family Micrococcaceae (the genera Micrococci and Staphylococci) representing >90% of the isolates
Order of detection:
Micrococcus luteus
Micrococcus lylae
Staphylococcus spp
Micrococcus spp
Staphylococcus epidermidis
Staphylococcus capitis
Staphylococcus hominis
Bacillus spp
Staphylococcus haemolyticus
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Study #5 EU GMP Grade C and D
clean areas = 2, 500 isolates
More diversity due to nature of operations and presence of water
Order of detection:
Micrococcus luteus
Bacillus spp.
Micrococcus lylae
Micrococcus spp.
Staphylococcus spp.
Bacillus spp
Bacillus cereus
Pseudomonads
Corynebacterium spp
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Outcomes Association between the microorganisms commonly
found in cleanrooms and those which are transient to (short-term or long term-residents on) human skin .
Low incidents of Bacillus spp.,
Possible transfer into the cleanrooms via personnel, dust, and material transfer .
Occasional, low-level incidences of microorganisms resident within the human body.
Where there is a water source, some microorganisms associated with water detected.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Outcomes Little variation over time
Variation signalled that something had gone wrong e.g. cleaning techniques, changes to personnel, HVAC failure
Sample types: Personnel samples: Gram-positive cocci occur most
frequently
Air samples: Gram-positive cocci occur very frequently (people shedding)
Surfaces: Gram-positive cocci occur quite frequently. Higher levels of Gram-positive rods (possible equipment transfer link) Where Gram-negative rods occur, this is from water on surfaces
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Outcomes Majority mesophilic
aerobic or facultatively aerobic bacteria.
Where specialist gases are used some anaerobic found.
Thermophiles and extremotolerant bacteria very rare.
Common fungi in cleanrooms are: Aspergillus, Penicillium and Trychophyton.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Summary Environmental monitoring limitations.
Fungal agars
Whether one or two culture media should be used for environmental monitoring.
The optimal incubation regime, where one medium is used.
Cleanroom microbiota.
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/
Pharmaceutical Microbiology: http://www.pharmamicroresources.com/